Mr. McErlane will lead all of Catalent’s Biologics businesses and global service offerings – including development, drug substance manufacturing, drug product fill-and-finish, cell and gene therapy, and analytical services.
She will be responsible for leading Catalent’s global human resources strategy, including talent acquisition, leadership development, diversity and inclusion, compensation and benefits, HR operations and technology, and performance management.
Mr. Masanovich will have responsibility for all aspects of Catalent’s global financial operations, including financial planning and analysis, controllership, public reporting and investor relations, capital markets activities, bill payment and collection, tax, and treasury.
OneBio Suite offers customers an integrated service to accelerate programs from development to manufacturing, including fill/finish and packaging, and support for clinical supply and commercial launch.
Julien Meissonnier will present at the upcoming 4th Symposium of the International Consortium for Advanced Medicines Manufacturing (ICAMM), to be held at the Royal Sonesta Hotel, Cambridge, Massachusetts, on April 27 – 28, 2023.
Catalent today announced that two of its clinical supply experts are to co-host workshop sessions at the upcoming Global Clinical Supplies Group (GCSG) Conference, to be held in Orlando, Florida, on April 23 – 26, 2023.